Anti-epileptic and Neuroprotective Effects of Ultra-low Dose NADPH Oxidase Inhibitor Dextromethorphan on Kainic Acid-induced Chronic Temporal Lobe Epilepsy in Rats

Neuroinflammation mediated by microglia and oxidative stress play pivotal roles in the development of chronic temporal lobe epilepsy (TLE). We postulated that kainic acid (KA)-Induced status epilepticus triggers microglia-dependent inflammation, leading to neuronal damage, a lowered seizure threshold, and the emergence of spontaneous recurrent seizures (SRS). Extensive evidence from our laboratory suggests that dextromethorphan (DM), even in ultra-low doses, has anti-inflammatory and neuroprotective effects in many animal models of neurodegenerative disease. Our results showed that administration of DM (10 ng/kg per day; subcutaneously via osmotic minipump for 4 weeks) significantly mitigated the residual effects of KA, including the frequency of SRS and seizure susceptibility. In addition, DM-treated rats showed improved cognitive function and reduced hippocampal neuronal loss. We found suppressed microglial activation-mediated neuroinflammation and decreased expression of hippocampal gp91phox and p47phox proteins in KA-induced chronic TLE rats. Notably, even after discontinuation of DM treatment, ultra-low doses of DM continued to confer long-term anti-seizure and neuroprotective effects, which were attributed to the inhibition of microglial NADPH oxidase 2 as revealed by mechanistic studies.

Impact of tin filter on the image quality of ultra-low dose chest CT: A phantom study on three CT systems

PURPOSE

The purpose of this study was to assess the impact of a tin filter on the image quality of ultra-low dose (ULD) chest computed tomography (CT) on three different CT systems.

MATERIALS AND METHODS

An image quality phantom was scanned on three CT systems including two split-filter dual-energy CT (SFCT-1 and SFCT-2) scanners and one dual-source CT scanner (DSCT). Acquisitions were performed with a volume CT dose index (CTDIvol) of 0.4 mGy, first at 100 kVp without tin filter (Sn), and second, at Sn100/Sn140 kVp, Sn100/Sn110/Sn120/Sn130/Sn140/Sn150 kVp and Sn100/Sn150 kVp for SFCT-1, SFCT-2 and DSCT respectively. Noise-power-spectrum and task-based transfer function were computed. The detectability index (d') was computed to model the detection of two chest lesions.

RESULTS

For DSCT and SFCT-1, noise magnitude values were higher with 100kVp than with Sn100 kVp and with Sn140 kVp or Sn150 kVp than with Sn100 kVp. For SFCT-2, noise magnitude increased from Sn110 kVp to Sn150 kVp and was higher at Sn100 kVp than at Sn110 kVp. For most kVp with the tin filter, the noise amplitude values were lower than those obtained at 100 kVp. For each CT system, noise texture and spatial resolution values were similar with 100 kVp and with all kVp used with a tin filter. For all simulated chest lesions, the highest d' values were obtained at Sn100 kVp for SFCT-1 and DSCT and at Sn110 kVp for SFCT-2.

CONCLUSION

For ULD chest CT protocols, the lowest noise magnitude and highest detectability values for simulated chest lesions are obtained with Sn100 kVp for the SFCT-1 and DSCT CT systems and at Sn110 kVp for SFCT-2.

Low dose pediatric chest computed tomography on a photon counting detector system - initial clinical experience

BACKGROUND

With the clinical release of a photon counting detector-based computed tomography (CT) system, the potential benefits of this new technology need to be evaluated clinically. Literature concerning this new generation of detector is sparse, especially in the field of pediatric radiology. Therefore, this study outlines our initial experience with ultra-low dose chest CT imaging on the new photon counting CT system.

MATERIALS AND METHODS

A pediatric phantom (1-year old, CIRS ATOM phantom, model 704 [CIRS-computerized imaging reference system, Norfolk, VA]) was scanned at different dose levels and different image quality levels to define a protocol for clinical examinations. Next, 20 consecutive pediatric non-contrast ultra-low dose chest CT examinations were evaluated for radiation dose and diagnostic image quality using a 4-point Likert-scale-1 = excellent, 4 = bad image quality-by two radiologists in a consensus reading. This retrospective analysis was approved by the local research ethics committee.

RESULTS

Chest CT examinations performed at ultra-low radiation dose (effective dose 0.19 ± 0.07 mSv; size-specific dose estimate 0.45 ± 0.14 mGy) in pediatric patients ages (2.6 ± 1.8 years) show good to excellent image quality for lung structures (1.4 ± 0.4) and moderate image quality for soft tissue structures (2.8 ± 0.2).

CONCLUSION

Pediatric ultra-low dose chest CT examinations are feasible with the new generation photon counting detector-based CT system. The benefits of this technology must be evaluated for pediatric patients from the outset.

Ultra-low-dose CTKUB: the new standard of follow-up of ureteric calculi not visible on plain radiograph?

PURPOSE

With sensitivities over 95%, non-contrast computer tomography of kidney, ureter and bladder (CTKUB) is the investigation of choice in renal colic to diagnose or exclude ureteric calculi. CTKUB delivers an average effective radiation dose of 5.4 millisievert (mSv) and is used to follow-up calculi not visible on plain X-ray, whereas plain radiography has a radiation exposure of 0.7 mSv and is used to follow-up radio-opaque calculi. We assessed the effectiveness of using ultra-low-dose CTKUB (ULDCTKUB) for the follow-up of ureteric calculi not visible on plain radiograph of the kidneys, ureter and bladder (KUB), as an emerging option to reduce radiation exposure compared to standard dose CTKUB.

METHODS

Between 2013 and 2016 we retrospectively analysed 86 patients who underwent ULDCTKUB for CTKUB-confirmed ureteric calculi that were not visible on plain radiography. Patients were identified from our Radiology Management System with additional information from electronic patient records.

RESULTS

98% of ULDCTKUBs were of diagnostic quality; two patients required further cross-sectional imaging. 67% of patients had passed their calculi after the initial diagnostic CTKUB. In the remaining 33% who had persistent calculi on ULDCTKUB, 20% required surgical intervention and 13% required no intervention. The mean ULDCTKUB effective radiation dose was six times lower than conventional CTKUB (0.8 vs 5.4 mSv). 67% of patients had a radiation dose equivalent to X-ray KUB (< 1 mSv).

CONCLUSION

ULDCTKUB is a reliable and safe follow-up investigation of ureteric calculi and has absorbed radiation doses similar to plain radiography and lower than annual background radiation. We advocate ULDCTKUB as the primary imaging modality in the follow-up of ureteric calculi not visible on plain radiograph.

Investigating ultra-low-dose total-body [18F]-FDG PET/CT in colorectal cancer: initial experience

PURPOSE

This study was to evaluate the effects of an ultra-low dose of [18F]-FDG on the image quality of total-body PET/CT and its lesion detectability in colorectal cancer (CRC).

METHODS

Sixty-two CRC patients who underwent total-body PET/CT (uEXPLORER, United Imaging Healthcare, Shanghai, China) with an ultra-low dose (0.37 MBq/kg) of [18F]-FDG were enrolled in this retrospective study. The PET images were reconstructed with the entire 15-min dataset first and then split into 13-, 8-, 5-, 4-, 3-, 2-, and 1-min duration groups to simulate fast scanning images. For simplicity, the images reconstructed with the data from 15 to 1 min were referred to as G15, G13, and so on until G1. Subjective image quality was assessed with 5-point Likert scales. The objective image quality parameters included the SUVmax, SUVmean, and signal-to-noise ratio (SNR) of the liver and blood pool and the SUVmax and tumor-to-background ratio (TBR) of the lesions. G15 served as the control to evaluate lesion detectability.

RESULTS

A total of 62 patients (43 men, 19 women; age 41-88, mean ± SD 64.0 ± 10.9 years) with 64 CRC primary tumor lesions and 10 low-grade intraepithelial neoplasia (LGIN) lesions were enrolled in this study. The subjective scores were highest for G15 (4.5 ± 0.5) and then decreased from G13 (4.3 ± 0.4) to G8 (3.7 ± 0.5). The liver SNR increased with the extension of acquisition time from G8 (17.2 ± 2.8) to G13 (20.6 ± 3.4) and G15 (21.9 ± 3.4). The liver SNR of G8 was not significantly different from that of G13 (p = 0.15) and was significantly different from that of G15 (p = 0.001). All 64 CRC lesions could be identified in all image groups, even on G1. One of ten LGINs was missed on G1, G2, and G3, and one LGIN was missed on G1, G2, G3, and G4. G15 served as the control, and 100% (48/48) lymph nodes could be found on G13 and G8 compared to 93.8% (45/48) lymph nodes on G5 and G4, 85.4% (41/48) lymph nodes on G3, 81.3% (39/48) lymph nodes on G2, and 77.1% (37/48) lymph nodes on G1. For liver metastases, there were no missed liver lesions on G13 and G8 and 3, 4, 6, 7, and 9 missed liver lesions on G5, G4, G3, G2, and G1, respectively. For other areas of metastasis, including the lung, peritoneum, and ovaries, there were no missed lesions in any group.

CONCLUSIONS

Total-body PET/CT with an ultra-low dose of [18F]-FDG can maintain satisfactory image quality and lesion detectability in CRC.

Ultra low doses and biological amplification: Approaching Avogadro's number

This paper describes evidence establishing that ultra-low doses of diverse chemical agents at concentrations from 10^-18 to 10^-24 M (e.g., approaching and/or less than 1 atom or molecule of a substance/cell based on Avogadro's constant - 6.022×10²³/mole) are capable of engaging receptor and intracellular signaling systems to elicit reproducible effects in a variety of species, from unicellular organisms to humans. Multiple experimental studies have shown that only one or very few molecules are needed to activate a cell and/or entire organism via cascade(s) of amplification mechanisms and processes. For example, ultra-low dose ligand exposure was able to activate both an individual cell, and ~3000 to 25,000 neighboring cells on average, by about 50%. Such activation of cells and whole organisms typically displayed hormetic-biphasic dose responses. These findings indicate that numerous, diverse phylogenetic systems have evolved highly sensitive detection and signaling mechanisms to enhance survival functions, such as defense against infectious agents, responses to diverse types of pheromone communications (e.g., alarm, sexual attraction), and development of several types of cellular protection/resilience processes. This suggests that ultra-low dose effects may be far more common than have been recognized to date. We posit that such findings have important implications for evolutionary theory, ecological and systems biology, and clinical medicine.

Ultralow doses of dextromethorphan protect mice from endotoxin-induced sepsis-like hepatotoxicity

Dextromethorphan, a wildly used over-the-counter antitussive drug, is reported to have anti-inflammatory effects. Previously, we and others have demonstrated that dextromethorphan at micromolar doses displays potent hepatoprotective effects and enhances mice survival in a sepsis model. Moreover, we also observed potent anti-inflammatory and neuroprotective effects of subpicomolar concentrations of dextromethorphan in rodent primary neuron-glial cultures. The purpose of this study was to provide a proof of principle that ultralow dose dextromethorphan displays anti-inflammatory and cytoprotective effects in animal studies. Here, we report that subpico- and micromolar doses of dextromethorphan showed comparable efficacy in protecting mice from lipopolysaccharide/d-galactosamine (LPS/GalN)-induced hepatotoxicity and mortality. Mice were given injections of dextromethorphan from 30 min before and 2, 4 h after an injection of LPS/GalN (20 μg/600 mg/kg). Our results showed that dextromethorphan at subpicomolar doses promoted survival rate in LPS/GalN-injected mice. Ultralow dose dextromethorphan also significantly reduced serum alanine aminotransferase activity, TNF-α level and liver cell damage of endotoxemia mice. Mechanistic studies using primary liver Kupffer cell cultures revealed that subpicomolar concentrations of dextromethorphan reduced the NADPH oxidase-generated superoxide free radicals from Kupffer cells, which in turn reduced the elevation of its downstream reactive oxygen species (iROS) to relieve the oxidative stress and decreased TNF-α production in Kupffer cells. Taken together, these findings suggest a novel therapeutic concept of using ultralow doses of dextromethorphan for the intervention of sepsis or septic shock.

Ultra-low dose chest computed tomography: Effect of iterative reconstruction levels on image quality

PURPOSE

To optimize image quality and radiation dose of chest CT with respect to various iterative reconstruction levels, detector collimations and body sizes.

METHOD

A Kyoto Kagaku Lungman with and without extensions was scanned using fixed ultra-low doses of 0.25, 0.49 and 0.74 mGy CTDI_vol, and collimations of 40 and 80 mm. Images were reconstructed with the lung kernel, filtered back projection (FBP) and different ASIR-V levels (10-100%). Contrast-to-noise ratios (CNR) were calculated for 12 mm simulated lesions of different densities in the lung. Image noise, signal-to-noise ratios (SNR), variations in Hounsfield units (HU), noise power spectrum (NPS) and noise texture deviations (NTD) were evaluated for all reconstructions. NTD was calculated as percentage of pixels outside 3 standard deviations to evaluate IR-specific artefacts.

RESULTS

Compared to the FBP, image noise reduced (5-55%) with ASIR-V levels irrespective of dose or collimation. SNR correlated positively (r ≥ 0.925, p ≤ 0.001) with ASIR-V levels at all doses, collimations, and phantom sizes. ASIR-V enhanced the CNR of the lesion with the lowest contrast from 12.7-42.1 (0-100% ASIR-V) at 0.74 mGy with 40 mm collimation. As expected, higher SNR and CNR were measured in the smaller phantom than the bigger phantom. Uniform HU were observed between FBP and ASIR-V levels at all doses, collimations, and phantom sizes. NPS curves left-shifted towards lower frequencies at increasing levels of ASIR-V irrespective of collimation. A positive correlation (r ≥ 0.946, p ≥ 0.001) was observed between NTD and ASIR-V levels. NTD of the FBP was not significantly (p ≤ 0.087) different from NTD of ASIR-V ≤ 20%. The data from the NPS and NTD indicates a blotchier and coarser noise texture at higher levels of ASIR-V, especially at 100% ASIR-V.

CONCLUSION

In comparison with the FBP technique, ASIR-V enhanced quantitative image quality parameters at all ultra-low doses tested. Moreover, the use of ASIR-V showed consistency with body size and collimation. Hence, ASIR-V may be useful for improving image quality of chest CT at ultra-low doses.

Feasibility of ultra low-dose coronary computed tomography angiography

There is an urgent need to develop new protocols to reduce radiation dose of coronary computed tomography angiography (CTA). The aim of this pilot study was to demonstrate the feasibility of an ultra-low dose CTA scanning.

Ultra-low Doses of Follicle Stimulating Hormone and Progesterone Attenuate the Severity of Polycystic Ovary Syndrome Features in a Hyperandrogenized Mouse Model

BACKGROUND

Polycystic-ovary syndrome (PCOS) is a reproductive illness characterized by hyperandrogenism and anovulation. Using hyperandrogenized mice, it was demonstrated that the oral administration of incremental dose of follicle stimulating hormone (FSH) attenuated some of PCOS characteristics. This work aimed to study the effect of ultra-low doses of combined FSH and progesterone orally administered on PCOS murine model. Moreover, the effect of sequential kinetic activation of administered hormones was tested.

METHODS

Thirty-two female mice were used as animal model (four groups of eight animals each). Mice were hyperandrogenized by injection of dehyidroepiandrosterone diluted in sesame oil. Control group received only oil. Simultaneously, each animal daily received per os an activated or a not-activated combination of FSH (0.44 pg) plus progesterone (0.44 pg) or saline solution as control. Serum testosterone, estradiol, progesterone and luteinizing hormone were analyzed as endocrine markers and a morphological study of antral follicle was conducted. Data were analyzed by one-way ANOVA, followed by multiple comparison test. The p<0.05 was considered significant.

RESULTS

Dehyidroepiandrosterone treatment increased both estradiol and progesterone serum levels, besides testosterone, while reduced luteinizing hormone (p<0.05); histological examination revealed an increase of cystic follicles (p<0.05). Irrespective of activation, the combined FSH and progesterone treatments restored estradiol level (p>0.05 vs. control group) and reduced cystic signs in the follicles (p<0.05 vs. dehyidroepiandrosterone treatment).

CONCLUSION

This study indicate that ultra-low doses of FSH and progesterone orally administrated can reduce the sternness of PCOS in the mouse model and open a route for the study of innovative approaches for PCOS treatment.